lamivudine has been researched along with Waldenstrom Macroglobulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chew, E; Seymour, JF; Thursky, K | 1 |
1 other study(ies) available for lamivudine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Rituximab; Virus Activation; Waldenstrom Macroglobulinemia | 2014 |